表紙
市場調查報告書
商品編碼
1064641

肢端小痣性黑色素瘤治療藥的全球市場:2021年∼2027年

Global Acral Lentiginous Melanoma Drugs Market 2021-2027

出版日期: | 出版商: Orion Market Research Pvt Ltd | 英文 100 Pages | 商品交期: 2-3個工作天內

價格
  • 全貌
  • 簡介
  • 目錄
簡介

全球肢端小痣性黑色素瘤治療藥的市場規模,在預測期間內預計以大幅度的年複合成長率擴大。手掌和腳底產生的黑色素瘤,是尖頭黑色素瘤。根據美國國立生物工程資訊中心,急性小痣性黑色素瘤佔全黑色素瘤的約2%∼3%。

本報告提供全球肢端小痣性黑色素瘤治療藥市場相關調查,市場概要,以及各治療,各地區的趨勢,及加入此市場的主要企業簡介等資訊。

目錄

第1章 報告概要

第2章 市場概要與洞察

  • 調查範圍
  • 分析師的洞察和目前市場趨勢

第3章 市場決策要素

  • 促進因素
  • 阻礙因素
  • 市場機會

第4章 市場區隔

  • 全球肢端小痣性黑色素瘤治療藥市場,各治療
    • 化療
    • 標靶治療
    • 免疫療法

第5章 地區分析

  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 義大利
    • 西班牙
    • 法國
    • 其他
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 其他
  • 其他地區

第6章 企業簡介

  • AbbVie Inc
  • Amgen
  • Bristol-Myers Squibb
  • Celgene
  • Eli Lilly & Co.
  • Johnson & Johnson
目錄
Product Code: OMR2024119

Global Acral Lentiginous Melanoma Drugs Market Size, Share & Trends Analysis Report by Therapy (Chemotherapy, Immuno Therapy, and Targeted Therapy), Forecast Period (2021-2027)

The global acral lentiginous melanoma drugs market is anticipated to grow at a considerable CAGR during the forecast period. Melanoma that develops on the palms or soles is known as acral lentiginous melanoma. Acral lentiginous melanoma begins as a flat area of discolored skin that progressively grows in size. According to the National Center for Biotechnology Information, acute lentiginous melanoma accounts for around 2%-3% of all melanomas

The global acral lentiginous melanoma drugs market is segmented based on therapy into chemotherapy, targeted therapy, and immune therapy. Geographically, the global acral lentiginous melanoma drugs market covers the analysis of four major regions including North America (the US and Canada), Europe (UK, Germany, Italy, Spain, France, and Rest of Europe), Asia-Pacific (China, Japan, India, and Rest of Asia-Pacific), and the Rest of the World.

Market Segmentation

1. Global Acral Lentiginous Melanoma Drugs Market Research and Analysis by Therapy

The Report Covers

  • Comprehensive research methodology of the global acral lentiginous melanoma drugs market.
  • This report also includes a detailed and extensive market overview with key analyst insights.
  • An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regional regulations and other government policies impacting the global acral lentiginous melanoma drugs market.
  • Insights about market determinants that are stimulating the global acral lentiginous melanoma drugs market.
  • Detailed and extensive market segments with the regional distribution of forecasted revenues.
  • Extensive profiles and recent developments of market players.

Table of Contents

1. Report Summary

  • 1.1. Research Methods and Tools
  • 1.2. Market Breakdown
    • 1.2.1. By Segments
    • 1.2.2. By Region

2. Market Overview and Insights

  • 2.1. Scope of the Report
  • 2.2. Analyst Insight & Current Market Trends
    • 2.2.1. Key Findings
    • 2.2.2. Conclusion

3. Market Determinants

  • 3.1. Motivators
  • 3.2. Restraints
  • 3.3. Opportunities

4. Market Segmentation

  • 4.1. Global Acral Lentiginous Melanoma Drugs Market by Therapy
    • 4.1.1. Chemotherapy
    • 4.1.2. Targetted Therapy
    • 4.1.3. Immuno Therapy

5. Regional Analysis

  • 5.1. North America
    • 5.1.1. United States
    • 5.1.2. Canada
  • 5.2. Europe
    • 5.2.1. UK
    • 5.2.2. Germany
    • 5.2.3. Italy
    • 5.2.4. Spain
    • 5.2.5. France
    • 5.2.6. Rest of Europe
  • 5.3. Asia-Pacific
    • 5.3.1. China
    • 5.3.2. India
    • 5.3.3. Japan
    • 5.3.4. Rest of Asia-Pacific
  • 5.4. Rest of the World

6. Company Profiles

  • 6.1. AbbVie Inc
  • 6.2. Amgen
  • 6.3. Bristol-Myers Squibb
  • 6.4. Celgene
  • 6.5. Eli Lilly & Co.
  • 6.6. Johnson & Johnson

LIST OF TABLES

  • 1. GLOBAL ACRAL LENTIGINOUS MELANOMA DRUGS MARKET RESEARCH AND ANALYSIS BY THERAPY, 2020-2027 ($ MILLION)
  • 2. GLOBAL ACRAL LENTIGINOUS MELANOMA CHEMOTHERAPY DRUGS MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 3. GLOBAL ACRAL LENTIGINOUS MELANOMA TARGETED THERAPY DRUGS MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 4. GLOBAL ACRAL LENTIGINOUS MELANOMA IMMUNO THERAPY DRUGS MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 5. GLOBAL ACRAL LENTIGINOUS MELANOMA DRUGS MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY, 2020-2027 ($ MILLION)
  • 6. NORTH AMERICAN ACRAL LENTIGINOUS MELANOMA DRUGS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2020-2027 ($ MILLION)
  • 7. NORTH AMERICAN ACRAL LENTIGINOUS MELANOMA DRUGS MARKET RESEARCH AND ANALYSIS BY THERAPY, 2020-2027 ($ MILLION)
  • 8. EUROPEAN ACRAL LENTIGINOUS MELANOMA DRUGS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2020-2027 ($ MILLION)
  • 9. EUROPEAN ACRAL LENTIGINOUS MELANOMA DRUGS MARKET RESEARCH AND ANALYSIS BY THERAPY, 2020-2027 ($ MILLION)
  • 10. ASIA-PACIFIC ACRAL LENTIGINOUS MELANOMA DRUGS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2020-2027 ($ MILLION)
  • 11. ASIA-PACIFIC ACRAL LENTIGINOUS MELANOMA DRUGS MARKET RESEARCH AND ANALYSIS BY THERAPY, 2020-2027 ($ MILLION)
  • 12. REST OF THE WORLD ACRAL LENTIGINOUS MELANOMA DRUGS MARKET RESEARCH AND ANALYSIS BY THERAPY, 2020-2027 ($ MILLION)

LIST OF FIGURES

  • 1. GLOBAL ACRAL LENTIGINOUS MELANOMA DRUGS MARKET SHARE BY THERAPY, 2020 VS 2027 (%)
  • 2. GLOBAL ACRAL LENTIGINOUS MELANOMA DRUGS MARKET SHARE BY GEOGRAPHY, 2020 VS 2027 (%)
  • 3. US ACRAL LENTIGINOUS MELANOMA DRUGS MARKET SIZE, 2020-2027 ($ MILLION)
  • 4. CANADA ACRAL LENTIGINOUS MELANOMA DRUGS MARKET SIZE, 2020-2027 ($ MILLION)
  • 5. UK ACRAL LENTIGINOUS MELANOMA DRUGS MARKET SIZE, 2020-2027 ($ MILLION)
  • 6. FRANCE ACRAL LENTIGINOUS MELANOMA DRUGS MARKET SIZE, 2020-2027 ($ MILLION)
  • 7. GERMANY ACRAL LENTIGINOUS MELANOMA DRUGS MARKET SIZE, 2020-2027 ($ MILLION)
  • 8. ITALY ACRAL LENTIGINOUS MELANOMA DRUGS MARKET SIZE, 2020-2027 ($ MILLION)
  • 9. SPAIN ACRAL LENTIGINOUS MELANOMA DRUGS MARKET SIZE, 2020-2027 ($ MILLION)
  • 10. REST OF EUROPE ACRAL LENTIGINOUS MELANOMA DRUGS MARKET SIZE, 2020-2027 ($ MILLION)
  • 11. INDIA ACRAL LENTIGINOUS MELANOMA DRUGS MARKET SIZE, 2020-2027 ($ MILLION)
  • 12. CHINA ACRAL LENTIGINOUS MELANOMA DRUGS MARKET SIZE, 2020-2027 ($ MILLION)
  • 13. JAPAN ACRAL LENTIGINOUS MELANOMA DRUGS MARKET SIZE, 2020-2027 ($ MILLION)
  • 14. REST OF ASIA-PACIFIC ACRAL LENTIGINOUS MELANOMA DRUGS MARKET SIZE, 2020-2027 ($ MILLION)
  • 15. REST OF THE WORLD ACRAL LENTIGINOUS MELANOMA DRUGS MARKET SIZE, 2020-2027 ($ MILLION)